FutureCrest Acquisition Corp.

Per the letter, accelerating the S-1 determines when gross proceeds deposit into the trust account and initiates the operational clock for public trading and potential redemptions. Because the SEC correspondence marks the final pre-effectiveness step, public shareholders will soon face the standard notice window for redemption elections if a de-SPAC transaction is tabled. The document also copies external counsel Ellenoff Grossman & Schole LLP, confirming standard regulatory clearance procedures are advancing. While routine post-comment-period paperwork, the accelerated timing compresses the interval between capital formation and target identification, which may force earlier capital deployment decisions relative to shareholder liquidity expectations.

This filing establishes the full terms of the SPAC's IPO, including the $250 million trust account ($10.00 per unit), a 24-month deadline to complete a business combination, redemption rights for public shareholders, founder shares purchased by the sponsor at $0.0035 per share, and 3.5 million private placement warrants at $2.00 each. Investors can now see the precise dilution, trust mechanics, and sponsor incentives. The document also discloses the management team's experience and potential conflicts of interest. The filing is necessary for the IPO to go effective and is the definitive source for all pre-deal structural details.

According to the filing's explicit text, the amendment formally strips away any implied SPAC sponsor pedigree, which redirects investor due diligence toward higher execution risk, longer sourcing timelines, and stricter oversight requirements during the SEARCHING phase. The added dilution and promoter conflict parameters establish the mechanical boundaries for trust value preservation and potential security holder value erosion, though the filing confirms zero alterations to the redemption deadline, trust account balance, or extension voting triggers. The SEC’s targeted request for historical context indicates the registration statement remains in pre-effective regulatory review rather than signaling a executed business combination, cash tender offer, or shareholder extension package.

Investors need this filing to understand the exact IPO terms: trust size ($250M, or $287.5M if over-allotment exercised), trust per-share value ($10.00), redemption rights (shareholders can redeem for cash pro rata from trust upon business combination), deadline (24 months, extendable with shareholder vote), and lack of a maximum redemption threshold. The document also details significant sponsor and management incentives (founder shares purchased for ~$0.0035/share, private placement warrants at $2.00/warrant), potential conflicts of interest, and the high dilution to public shareholders (up to 114.5% in maximum redemption scenario).

Per the letter, SEC reviewers noted they were unable to locate required historical disclosure on the sponsor’s prior SPAC background and observed that management has not contacted prospective target businesses previously evaluated and rejected in earlier ventures. This signals active regulatory scrutiny over sponsor track record transparency and target-sourcing discipline before capital is raised. The commentary cites precise draft locations (page 92 for dilution tables, page 111 for target sourcing) and mandates compliance with Regulation S-K Items 1602(a)(3), 1602(a)(5), 1602(c), and 1603(a)(3). For follow-up, the letter lists staff contacts: Eric McPhee at 202-551-3693, Mark Rakip at 202-551-3573, David Link at 202-551-3356, and Pam Howell at 202-551-3357. Until these comments are resolved and the S-1 prices, deal progress is structurally paused, and no shareholder actions regarding redemptions or extensions can occur.

This filing establishes the terms for a new SPAC led by a high-profile management team with domain expertise in AI, digital assets, fintech, and technology. The trust value per share is $10.00. The initial 24-month deadline runs from the closing of this offering. For investors tracking this SPAC, the document outlines the redemption mechanics, dilution from founder shares (20% of post-offering shares purchased for $25,000), and sponsor economics. The SPAC is currently in the 'searching' phase with no target identified.

What changed: Quarterly report (Form 10-Q) for FutureCrest Acquisition Corp. for the quarterly period ended September 30, 2025 – the company's first periodic report since its inception and initial public offering (IPO) on September 29, 2025. The company completed its IPO of 28,750,000 units at $10.00 per unit, generating gross proceeds of $287.5 million. Simultaneously, it sold 3,500,000 private placement warrants for $7.0 million. Net IPO proceeds of $287.5 million were placed in a trust account ($10.00 per public share). Transaction costs totaled $17.9 million. As of September 30, 2025, the company held $1.4 million in cash outside the trust, had working capital of $1.3 million, and reported a net loss of $60,837 for the three months ended September 30, 2025, and $77,978 since inception (June 9, 2025). No business combination target has been identified, and no substantive discussions have occurred. Why it matters: This filing establishes the post-IPO financial baseline for the SPAC. It confirms the trust value at $10.00 per share (redemption value), the 24-month deadline to complete a business combination (by September 29, 2027), the sponsor's founder share structure and lock-up terms, and the warrant terms. Investors tracking redemption mechanics, extension possibilities, and sponsor conduct now have a clear starting point for evaluating the SPAC's search process.

What changed: Routine compliance exhibit (Exhibit 99.1, a Joint Filing Agreement) attached to a Schedule 13G beneficial ownership report. The filing records a Rule 13d-1(k) agreement signed on November 14, 2025, by Anson Funds Management LP, Anson Management GP LLC, Tony Moore, Anson Advisors Inc., Amin Nathoo, and Moez Kassam to jointly file a Statement on Schedule 13G concerning Equity Units of FutureCrest Acquisition Corp. With respect to redemption deadlines, trust value, extensions, deal progress, and sponsor conduct: the document contains no operational covenants, specifies no purchase prices, share counts, or acquisition targets, and does not modify the SPAC’s stated SEARCHING status or trust accounting. Each signatory expressly accepts sole responsibility for the accuracy of their own reported information, and none assumes liability for the others’ disclosures. No timeline for a business combination or extension vote is established or referenced. Why it matters: For investors monitoring FCRS, this exhibit confirms that the named funds and individuals are aggregating their Section 13(g) reporting duties for the company’s equity units. Because the submitted text includes only the execution page of the joint filing agreement, it discloses neither the quantity of units controlled, the aggregate percentage ownership, nor any strategic intent regarding a de‑SPAC transaction, sponsor compensation, or unit holder liquidation rights. Consequently, it does not independently alter redemption calculations or trigger trust distribution events. Its utility lies solely in mapping the coordinated reporting umbrella around Anson-affiliated stakeholders, allowing investors to track when a subsequent 13G amendment surfaces with concrete position data that could indicate accumulated voting leverage ahead of any future prospectus or proxy solicitation.

What changed: Form 8-K current report and accompanying press release (Exhibit 99.1) announcing the separate listing and trading of FutureCrest Acquisition Corp.'s Class A ordinary shares and redeemable warrants. Per the Company, commencing November 17, 2025, holders of units sold in its initial public offering may elect to separately trade the Class A ordinary shares and redeemable warrants included in those units. Each unit comprises one Class A ordinary share (par value $0.0001 per share) and one-quarter of one redeemable warrant. Upon separation, no fractional warrants will be issued and only whole warrants will trade. Holders must instruct their brokers to contact Continental Stock Transfer & Trust Company to effect the separation. The separated Class A ordinary shares and warrants will trade on the NYSE under the symbols 'FCRS' and 'FCRS.WS', respectively, while unseparated units will continue trading under 'FCRS.U'. The Company stated each whole warrant entitles the holder to purchase one ordinary share at an exercise price of $11.50 per share. Why it matters: This announcement adjusts the tradability mechanics of the SPAC’s capital structure, enabling investors to hold or liquidate equity and warrant positions independently without altering the trust account, extending redemption deadlines, or changing the pending business combination search. Per the press release, the Company continues to focus its acquisition strategy on the food and beverage industry. Personnel and operational disclosures attributed to the Company identify Mr. Thomas Lee as Chief Executive Officer and Director, and Chief Financial Officer Chi Tsang as the signing officer. Cantor Fitzgerald & Co. is identified as the entity distributing copies of the IPO prospectus at 499 Park Avenue, New York, NY 10022.

What changed: A Form 8-K current report filed by FutureCrest Acquisition Corp. disclosing the consummation of its initial public offering, the concurrent private placement of warrants, the funding of the trust account, and the attached audited balance sheet and financial statement notes as of September 29, 2025. Item 8.01 of the filing states that on September 29, 2025, the company sold 28,750,000 units at $10.00 per unit for $287,500,000 in gross proceeds, including a full exercise of 3,750,000 over-allotment units. Simultaneously, the company sold 3,500,000 private placement warrants at $2.00 per warrant for $7,000,000 in aggregate, with 2,250,000 sold to FutureCrest Acquisition Sponsor LLC and 1,250,000 sold to Cantor Fitzgerald & Co. According to the audited balance sheet in Exhibit 99.1, $287,500,000 was placed in a U.S.-based trust account administered by Continental Stock Transfer & Trust Company, leaving $1,397,215 in corporate cash and $1,319,306 in working capital. Note 2 discloses total transaction costs of $17,861,874, broken down by the company as $5,000,000 in cash underwriting fees, $12,250,000 in deferred underwriting fees, and $611,874 in other offering costs. Following the over-allotment exercise, Note 5 states the sponsor now holds 7,187,500 Class B founder shares, eliminating previously disclosed forfeiture provisions. The notes further state the company has not identified a target, has not commenced operations, and will generate zero operating revenues until completing a business combination. A subsequent event note discloses that on October 1, 2025, the company returned $22,500 to the sponsor. The filing also references the One Big Beautiful Bill Act signed on July 4, 2025, but management states it expects no significant financial statement impact. Why it matters: Investors tracking redemption mechanics should note the filing sets a 24-month completion window from the September 29, 2025 IPO close, establishing the deadline before mandatory liquidation and distribution of trust funds can occur. The company’s letter agreement, as cited in the notes, waives founder share redemption rights and commits the sponsor to be liable if third-party claims reduce trust assets below the lesser of $10.00 per public share or the actual per-share trust amount, though the company explicitly cautions it cannot assure the sponsor possesses sufficient funds to satisfy those obligations. The filing establishes warrant terms allowing purchase of Class A ordinary shares at $11.50, exercisable 30 days post-business combination and expiring five years later, with a redemption trigger set at a $18.00 share price. Because the company retains $1,397,215 outside the trust and management’s written assessment states sufficient liquidity exists to fund operations within one year, investors can monitor whether pre-combination expenditures trigger the disclosed possibility of up to $1,500,000 in convertible working capital loans from the sponsor. All timeline, capital structure, and obligation references are sourced directly from Item 8.01, the Exhibit 99.1 balance sheet, and Notes 1 through 6.

What changed: Form 4 — Statement of Changes in Beneficial Ownership (insider ownership report). Regarding mechanics: The filing contains no updates to redemption deadlines, trust account valuations, extension provisions, business combination progress, or target announcements. Director Eric Semler instead executed a 2025-09-29 open-market purchase of 500,000 shares, resulting in a reported post-transaction ownership position of 500,000 shares. Regarding other substance: The document contains zero claims or data regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or additional personnel. As a result, this administrative disclosure functions as the sole substantive update for the filing cycle. Why it matters: Investors tracking sponsor conduct and insider alignment should note that executing an open-market purchase of 500,000 shares represents direct, out-of-pocket capital deployment by a director during the SEARCHING phase. While structurally inert regarding calendar dates or trust mechanics, the transaction establishes a clear ownership baseline. Subsequent Form 4 filings can now be benchmarked against this 500,000-share position to detect accelerated buying that often correlates with undisclosed target pipeline development, upcoming extension votes, or impending redemptions.

What changed: Form 8-K reporting the closing of FutureCrest Acquisition Corp.'s initial public offering, including full exercise of the over-allotment option, private placement of warrants, and execution of various IPO-related agreements. The company consummated its IPO of 28,750,000 units at $10.00 per unit for gross proceeds of $287,500,000; $287,500,000 was deposited into the trust account ($10.00 per share). Private placement of 3,500,000 warrants to sponsor (2,250,000) and underwriter (1,250,000) for $7,000,000 total. A 24-month deadline from closing (September 29, 2027) applies. Directors appointed and committees formed. Amended and restated charter and other standard IPO agreements became effective. Why it matters: The filing establishes the trust value at $10.00 per share, confirms the 24-month deadline, and details sponsor/insider lock-ups and redemption mechanics. No business combination target has been identified. The company is searching and has stated a focus on AI, digital assets, fintech, infrastructure, robotics, and communications. This is a routine IPO closing filing, but it provides the baseline trust value and timeline for future tracking.

What changed: Final prospectus (424B4) for the initial public offering of FutureCrest Acquisition Corp., a blank check company (SPAC) seeking a business combination. FCRS filed its final prospectus for a $250 million IPO (25,000,000 units at $10.00 per unit, with a 45-day over-allotment option for up to 3,750,000 additional units). The trust account will initially hold $10.00 per unit ($250 million, or $287.5 million if over-allotment is exercised in full). The sponsor and Cantor Fitzgerald are purchasing 3,500,000 private placement warrants at $2.00 each ($7 million total). The prospectus confirms the standard redemption mechanics: public shareholders may redeem at $10.00 per share (plus interest, less taxes) upon completion of a business combination, and the company has 24 months from closing to consummate a deal. No target has been selected. No substantive discussions with any target have occurred. The filing also details the management team (led by Thomas J. Lee and Chi Tsang), the focus on AI, digital assets, fintech, infrastructure, robotics, and communications, and the various conflicts of interest and dilution risks. Why it matters: This is the IPO prospectus, establishing the baseline trust value ($10.00 per unit), redemption mechanics, deadline (24 months), and sponsor terms. It provides the framework for all future actions — extensions, target announcements, shareholder votes, and redemptions. The document also contains extensive risk factors and disclosure about sponsor incentives, dilution, and potential conflicts. For investors tracking redemption deadlines and trust value, this is the governing document.

What changed: A Form 8-A filing registering certain classes of securities (Units, Class A ordinary shares, and redeemable warrants) for quotation on The New York Stock Exchange pursuant to Section 12(b) of the Securities Exchange Act of 1934. This filing serves as an administrative listing registration that formally brings the registered securities classes onto the NYSE order book following the initial public offering referenced in the Form S-1 originally filed September 5, 2025 (File No. 333-290088). It does not amend redemption deadlines, adjust the trust account balance, trigger or modify extension provisions, advance any business combination target search or negotiation, or disclose sponsor conduct. The registrant incorporated by reference the security descriptions from the original registration statement, and Chief Executive Officer Thomas J. Lee executed the filing on September 25, 2025. Why it matters: For investors tracking redemption calendars and capital maintenance, this filing confirms the formal NYSE listing infrastructure for the units, shares, and warrants is active, establishing the procedural baseline for secondary market trading ahead of a potential business combination. The filing explicitly sets forth the whole warrant exercise price of $11.50 and the Class A ordinary shares par value of $0.0001 per share. It contains no forward-looking statements, commercial claims, customer metrics, revenue projections, technology disclosures, partnership announcements, or litigation updates. Consequently, the document functions purely as a regulatory compliance step without altering cash preservation timelines, merger voting schedules, or sponsor fiduciary obligations.

What changed: A Form 3 insider ownership report filed on 2025-09-25 for FutureCrest Acquisition Corp., submitted by reporting person Ginns Seth in his capacity as director. The filing explicitly states 'No non-derivative transactions or holdings reported,' confirming the director's equity position remained static during the reporting window. From a SPAC mechanics standpoint, this indicates no insider purchases, sales, warrant exercises, or conversion activity that would alter share overhang, fund liquidity buffers, or signal pre-dealer positioning. Why it matters: Although the document contains zero data on redemption calendars, trust account movements, extension proposals, business combination pipelines, or sponsor governance actions, it functions as a compliance checkpoint rather than a strategic inflection point. The issuer and director made no claims regarding customer traction, revenue, addressable market, technology roadmaps, partnership execution, litigation posture, or executive staffing. Consequently, the filing does not shift the company's SEARCHING status, modify trust/share expectations, or provide actionable signals for deal timing or shareholder exit windows. Investors tracking capital deployment or extension votes should continue to rely on proxy solicitations, proposed business combination agreements, and trustee distributions rather than drawing directional conclusions from this routine ownership attestation.